Showing 941 - 960 results of 2,245 for search '"hormone"', query time: 0.05s Refine Results
  1. 941

    Gender, FT4 levels, T stage, and BMI as predictors of TSH levels in thyroid cancer patients by Sen Zhang, Shuli Niu, Ling Zhou

    Published 2025-01-01
    “…BackgroundAfter initial treatment, levothyroxine (LT4) administration is necessary for thyroid cancer patients to achieve target thyroid-stimulating hormone (TSH) levels. However, the clinical efficacy of weight-based LT4 dosing has been suboptimal, highlighting the need to identify factors influencing the attainment of desired TSH levels and guide personalized treatment.MethodsWe constructed a retrospective cohort comprising 215 patients diagnosed with thyroid cancer. …”
    Get full text
    Article
  2. 942

    The protective effects of active ingredients from acrorus tatarinowii on sperm and their molecular mechanisms by Zonglin Lu, Haiyang Zhao, Hui Wang, Xin Wang, Zixue Sun

    Published 2025-01-01
    “…Methods Initially, using the TCMSP and Disgenet databases, active ingredients of Acrorus tatarinowii were identified and their target genes associated with sperm-related diseases were elucidated.Subsequently, an oligoasthenozoospermia mouse model was induced and treated with Acrorus tatarinowii. Serum hormone levels were assessed by ELISA, testicular histopathology by HE staining, and target gene expression by qPCR and Western blotting. …”
    Get full text
    Article
  3. 943

    THERAPY FOR IRREGULAR MENSTRUATION WITH ACUPUNTURE AND HERBAL PEGAGAN (CENTELLA ASIATICA (L.)) by Evin Dwi Prayuni, Ario Imandiri, Myrna Adianti

    Published 2019-01-01
    “…Menstruation bleeding is complex interaction result wich involve hormone system and body system, that are hypothalamus, hypofisis, ovarium and uterus. …”
    Get full text
    Article
  4. 944

    Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome by Mimouni, Nour El Houda, Giacobini, Paolo

    Published 2024-04-01
    “…However, the underlying mechanisms of its transmission remain unknown, thus limiting the development of effective therapeutic strategies.This article highlights how an altered fetal environment (prenatal exposure to high levels of anti-Müllerian hormone) can contribute to the onset of PCOS in adulthood and lead to the transgenerational transmission of neuroendocrine and metabolic traits through alterations in the DNA methylation process.The originality of the translational findings summarized here involves the identification of potential biomarkers for early diagnosis of the syndrome, in addition to the validation of a promising therapeutic avenue in a preclinical model of PCOS, which can improve the management of patients suffering from the syndrome.…”
    Get full text
    Article
  5. 945

    Effects of Long Distance Transportation on Honey Bee Physiology by Kiheung Ahn, Xianbing Xie, Joseph Riddle, Jeff Pettis, Zachary Y. Huang

    Published 2012-01-01
    “…There were no significant differences between S and T colonies in juvenile hormone titers. Protein content in head showed no significant differences between S and T either in 7-day-old or 17-day-old bees of MI trial, but GA trial showed a significant reduction in bees experiencing transportation. …”
    Get full text
    Article
  6. 946

    The role of insulin signaling with FOXO and FOXK transcription factors by Masaji Sakaguchi

    Published 2024-10-01
    “…Insulin is an essential hormone for animal activity and survival, and it controls the metabolic functions of the entire body. …”
    Get full text
    Article
  7. 947

    Antifibrotic Activity of Acylated and Unacylated Ghrelin by Elia Angelino, Simone Reano, Michele Ferrara, Emanuela Agosti, Andrea Graziani, Nicoletta Filigheddu

    Published 2015-01-01
    “…The acylated form, through its receptor GHSR-1a, stimulates appetite and growth hormone (GH) release. Although unacylated ghrelin does not bind or activate GHSR-1a, it shares with the acylated form several biological activities. …”
    Get full text
    Article
  8. 948

    FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management by Muhammad Mazhar Azam, Sameen Mukhtar, Muhammad Haris, Fatima Laique, Suhaina Amir, Mubashir Mohiuddin, Bibek Giri

    Published 2024-12-01
    “…MASH is a growing global health concern, and resmetirom offers a novel therapeutic option by targeting liver pathophysiology through thyroid hormone receptor-beta activation. This mechanism effectively reduces fibrosis markers, improves liver enzyme levels, and minimizes liver fat buildup. …”
    Get full text
    Article
  9. 949

    Synthesis and Biological Evaluation of New CRH Analogues by Spyridon Papazacharias, Vassiliki Magafa, Nicole Bernad, George Pairas, Georgios A. Spyroulias, Jean Martinez, Paul Cordopatis

    Published 2010-01-01
    “…A series of 7 new human/rat Corticotropin Releasing Hormone (h/r-CRH) analogues were synthesized. The induced alterations include substitution of Phe at position 12 with D-Phe, Leu at positions 14 and 15 with Aib and Met at positions 21 and 38 with Cys(Et) and Cys(Pr). …”
    Get full text
    Article
  10. 950

    Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies by Tilman Todenhöfer, Arnulf Stenzl, Lorenz C. Hofbauer, Tilman D. Rachner

    Published 2015-01-01
    “…Maintaining bone health remains a clinical challenge in patients with prostate cancer (PC) who are at risk of developing metastatic bone disease and increased bone loss due to hormone ablation therapy. In patients with cancer-treatment induced bone loss (CTIBL), antiresorptive agents have been shown to improve bone mineral density (BMD) and to reduce the risk of fractures. …”
    Get full text
    Article
  11. 951

    The glucocorticoid hypothesis of depression: history and perspectives by G. T. Shishkina, N. N. Dygalo

    Published 2016-05-01
    “…Although the increase in hormone levels following a short-term intervention is directed towards rapid mobilization of the body’s efforts for overcoming potentially dangerous situation, a long-term exposure to stress or glucocorticoids may have negative consequences for mood or behavior. …”
    Get full text
    Article
  12. 952

    Recurrent Hydatidiform Moles: A Clinical Challenge—A Case Report and an Update on Management and Therapeutical Strategies by S. Riccio, F. Galanti, M. Scudo, L. Di Troia, M. G. Ferrillo, F. Manzara, P. Ianiri, F. A. Battaglia

    Published 2023-01-01
    “…After the return to the baseline values of the beta-human chorionic gonadotropin hormone, a combined oral contraceptive therapy was proposed, and the patient was invited to undergo in vitro fertilization (IVF) techniques, specifically oocyte donation, to reduce the possibility of similar future cases of RHMs. …”
    Get full text
    Article
  13. 953

    SMARCA4-Deficient Carcinoma of Unknown Primary Presenting with Fatal Paraneoplastic Hypercalcemia in a Heart Transplant Recipient: First Report in a Male Patient by Abbas Agaimy, Deike Strobel, Thomas Strecker

    Published 2017-01-01
    “…The serum parathyroid hormone-related protein (PTHrp) was significantly elevated (241 pg/ml; reference value < 57). …”
    Get full text
    Article
  14. 954

    Possible Involvement of TLRs and Hemichannels in Stress-Induced CNS Dysfunction via Mastocytes, and Glia Activation by Adam Aguirre, Carola J. Maturana, Paloma A. Harcha, Juan C. Sáez

    Published 2013-01-01
    “…The corticotropin-releasing hormone and glucocorticoids are critical players in stress-induced mastocyte degranulation and potentiation of glial inflammatory responses, respectively. …”
    Get full text
    Article
  15. 955

    Development of the anterior pituitary: diverse lineages of the stem/progenitor cells by Yukio Kato, Takako Kato

    Published 2024-06-01
    “…Differentiation of endocrine cells in the pituitary gland leads to hormone synthesis, secretion into the capillary network, and transportation to target organs. …”
    Get full text
    Article
  16. 956

    Genome-wide analysis and characterization of TPD1 family proteins in pearl millet (Cenchrus americanus): Insights into reproductive regulation and phytohormone responses. by Zainab M Almutairi

    Published 2025-01-01
    “…Treatment with phytohormones showed that the expression of CaTPD1s was repressed by hormone treatments except CaTPD1_Ch4.1 and CaTPD1_Ch4.3 which are highly expressed in response to brassinolide and auxin, respectively. …”
    Get full text
    Article
  17. 957

    Serum Analysis in Patients with Temporomandibular Disorders: A Controlled Cross-Sectional Study in Norway by Kordian Staniszewski, Henning Lygre, Trond Berge, Annika Rosén

    Published 2019-01-01
    “…To evaluate essential proteins, hormones, electrolytes, and vitamins in serum from TMD patients, a standard blood sample analysis was performed in 60 TMD patients and 60 healthy controls matched for age and gender, retrieving 19 different analyses. …”
    Get full text
    Article
  18. 958

    Charge-Based Inhibitors of Amylin Fibrillization and Toxicity by Sharadrao M. Patil, Andrei T. Alexandrescu

    Published 2015-01-01
    “…To test the hypothesis that electrostatic repulsion is an important force opposing amyloid fibril assembly, we designed peptides that substitute strings of positively or negatively charged residues into the sequence of the amyloidogenic hormone amylin, which contributes to type 2 diabetes pathology. …”
    Get full text
    Article
  19. 959

    Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix by Shawn Y. Ong, Josephine Taverna, Clint Jokerst, Thomas Enzler, Emad Hammode, Elisa Rogowitz, Myke R. Green, Hani M. Babiker

    Published 2015-01-01
    “…We describe a case of DIC XFL caused by prostate cancer (PC) successfully treated with a single injection of degarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist. This led to prompt control of the patient’s coagulopathy within ten days of treatment. …”
    Get full text
    Article
  20. 960

    Spontaneous Regression of Uterine Arteriovenous Malformations with Conservative Management by Keiko Mekaru, Sugiko Oishi, Kozue Akamine, Chiaki Heshiki, Yoichi Aoki

    Published 2017-01-01
    “…If estradiol was >300 pg/mL when AVM was diagnosed, then a gonadotropin-releasing hormone agonist was administered. All three women underwent follow-up observation, revealing spontaneous mass disappearance. …”
    Get full text
    Article